News

Pharmaceutical Technology37m
FDA accepts Novo Nordisk’s NDA submission for weight management therapy
The US FDA has accepted Novo Nordisk’s new drug application (NDA) submission for the 25 mg oral formulation of Wegovy ...
Pharmabiz37m
US FDA accepts Novo Nordisk’s NDA submission for oral semaglutide 25 mg for treatment of obesity
Plainsboro, New Jersey Monday, May 5, 2025, 14:00 Hrs [IST] ...
Healthcare Dive46m
Cigna doubles down on GLP-1 support programs with 2 new launches
On Friday, the company’s health services unit Evernorth unveiled new programs in a reliable growth area: helping payers ...